Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), bought 150 shares at $77.11 ($12K) on 2014-09-15, disclosed to the SEC on 2014-09-17.
Seasonal purchase ($12k) by Chief Scientific Officer — this insider has traded HTWR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |